N
Google TrendCOVENTRY VS NEWCASTLE (2000+) — Premier League LIVE: Coventry City vs Newcastle United - build-up, team news, score, text commentary & match stats
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:coventry vs newcastle2000+levante - sevilla2000+servicio de control de inmigración y aduanas1000+indigo girls200+afc champions league200+essie fall nail polish trends 2026200+champions league schedule500+geomagnetic storm aurora visibility northern us500+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Progression of recurrent" (30 stories)

Top Headline Story

New therapy delays progression of recurrent prostate cancer
Lead StoryUCLA Healthgeneral
Nov 12, 2025

New therapy delays progression of recurrent prostate cancer

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxObmRoY3RpZ0tMaFJBcGc3T1NiQUk0VFJONWhyQ0JLOTdKcUNJX2h4T0JudFZ6WU1IZ09Wbkd1ajExYThHbW43b0hMTGcybzFMb0QxdXQ1aW55ODFiVkJvNS1BMkpMRTdUNHJxYjhzYjJ3RVA3cExYZkNSSmFWVVFHeW5RLTJ2bFRjdnUxV0tDZmJJX3B3NHpvcHhEcnI?oc=5" target="_blank">New therapy delays progression of recurrent prostate cancer</a>  <font color="#6f6f6f">UCLA Health</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
2000+24m ago

coventry vs newcastle

Premier League LIVE: Coventry City vs Newcastle United - build-up, team news, score, text commentary & match stats

Filter stories
2000+24m ago

levante - sevilla

Levante - Sevilla en directo

Filter stories
1000+24m ago

servicio de control de inmigración y aduanas

"La cosa se está poniendo tensa": manifestantes se enfrentan a agentes migratorios en Oregon

Filter stories
200+24m ago

indigo girls

Indigo Girls cancel show after tour bus driver dies in highway crash

Filter stories

Search Results for "Progression of recurrent"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
How Coffee Affects Prostate Cancer Risk, Progression, and Recurrence
Everyday Healthgeneral

How Coffee Affects Prostate Cancer Risk, Progression, and Recurrence

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQVnlCWk80RHFndTZ6dlVZSzJxOUZEd0Y1OEdKNjNUeV9oNEpQazJpN2NwVDFLR05tWnY1eXBNd2JGMGc3b0RaVjFId1VPSnp6MHdqZWZuUTZZY1RCRTNQNU1sQllnTEtiMU9KeTE4SGR6TFdXVTBUQ0hJSUxIdHhiRUNsY3BBUVUtVDhjdzNRcEVFZVAzdXJWNEVHR2UybWxJd3dHcnJURzJqdXBiWF80U0x0RVQ?oc=5" target="_blank">How Coffee Affects Prostate Cancer Risk, Progression, and Recurrence</a>  <font color="#6f6f6f">Everyday Health</font>

Read Full StoryMore like this
Risk Factors for Progression to Chronicity or Recurrent Episodes in Pediatric Acute Urticaria: A 1-Year Cohort Study
Dove Medical Pressgeneral

Risk Factors for Progression to Chronicity or Recurrent Episodes in Pediatric Acute Urticaria: A 1-Year Cohort Study

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxPOFhuNFhKTHM2Nk9SZ2VSd2hwY09GUUZxUzF6dHVjVWZOczNndURicUw1MjJTSDlpNzIxcEcxb0pyQzd2amR5anUzSFVWdFFXMzJIUFBIMkgtOFBCNVJOdEJWUmVrZm9qTlE4LURPaWpLM0piMjJYalZZSHZ1djRDVVRWRUlWYTBRZlN1VFlqT3AzQ1lPaFV0UTQ4V1J3WC00bGtlS3NfalVlWGUtWVdqT0JIOFR6WFgwaGVMSE5rSS0tb2ZqcnVFRm82bw?oc=5" target="_blank">Risk Factors for Progression to Chronicity or Recurrent Episodes in Pediatric Acute Urticaria: A 1-Year Cohort Study</a>  <font color="#6f6f6f">Dove Medical Press</font>

Read Full StoryMore like this
Durable progression-free survival with first-line sintilimab plus chemotherapy followed by sintilimab maintenance in PD-L1-high recurrent cervical cancer: a case report
Frontierstech

Durable progression-free survival with first-line sintilimab plus chemotherapy followed by sintilimab maintenance in PD-L1-high recurrent cervical cancer: a case report

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOUlBWb04xR0hIbVNOSmJDZzhfT29pSVpNZk9GWE1TbEswQWIxeDdObTRIM21hNlItTTdvMVVhSzdXbDZITUlVeGFlcWVHcDR3aTJITnpJdWx3TzY3cEJRZVY0RXZ3MUJ0YTd5cG5vd3ExYlBlRFE2QXZrdGRjOTV1bUhuekJKbktOWE53RVpB?oc=5" target="_blank">Durable progression-free survival with first-line sintilimab plus chemotherapy followed by sintilimab maintenance in PD-L1-high recurrent cervical cancer: a case report</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Collagen gene expression profiles predict recurrence and progression of DCIS to IDC
Naturegeneral

Collagen gene expression profiles predict recurrence and progression of DCIS to IDC

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBxcy0wY1ZaQk1uMWFYZ2R6S1g0TjdMZ01fOU1SRlRmLUlwaERPLVpNNmZSemdkRmV4REVNQlNtV0VnU1dsWHpHOFQ4VlN5ZlVCNS1Pa096dG5JalVmOEFr?oc=5" target="_blank">Collagen gene expression profiles predict recurrence and progression of DCIS to IDC</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Biochemically Evolving Acute Hepatic Porphyria With Postpartum Progression to Severe Recurrent Neurovisceral Disease
Cureusgeneral

Biochemically Evolving Acute Hepatic Porphyria With Postpartum Progression to Severe Recurrent Neurovisceral Disease

<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxOUWZQWWdJQS1TR01iRVZ6dDZlLUtqQ0kyYWJELTZILUVib1lXRVN0Tlg1Zml1VElzY0phWVlNLTZ2cVFNRHN1clYtdTVpdVh3eTNhS2xjdGZIYTR0WkpQRWRGMlJwN2prVXlCNWRfZWp6WkVSbDN6MllWb2p3YUtIbkY1d01mSGM3WUZEajBzUTdZZERMS3JJY2IzekhiNkVjRGNweDM2UmdKMUsxb1dYNU1VVWNQTlcxNGJfaVhmUFJaZGxpMjVqUnVqU2dCZnlMSUd1Ny1aVjMxY01wdDZENEJ3eDUzVEZCZEFn?oc=5" target="_blank">Biochemically Evolving Acute Hepatic Porphyria With Postpartum Progression to Severe Recurrent Neurovisceral Disease</a>  <font color="#6f6f6f">Cureus</font>

Read Full StoryMore like this
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy
Business Wiretech

KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy

<a href="https://news.google.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?oc=5" target="_blank">KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR) Tumors Compared to Chemotherapy</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Immunotherapy Combination Shows Promise in Recurrent Ovarian Cancer
EMJworld

Immunotherapy Combination Shows Promise in Recurrent Ovarian Cancer

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPZlJiVmhNRjQxLXh1NmJPMV9kQ29UOGJGTjR6MGIwaF9Mc2pMck0yY0FSeHRRR2J2anJ3TENtbWROcHBZY3lLQzBDZVRZUVZjUFdjVERKeFJDMEhuVXZXNk9rTVozY0xKdVltR3NLRFc2MndOVFFGQ1F2R2loMnZ0VF82WU91QUw2b0pZTXR0SXJzTHpXb01XY1MwRXAxLXFVWmU1emZjZ0FKdS1Genc?oc=5" target="_blank">Immunotherapy Combination Shows Promise in Recurrent Ovarian Cancer</a>  <font color="#6f6f6f">EMJ</font>

Read Full StoryMore like this
Late recurrence and histological progression of a cervical intradural extramedullary solitary fibrous tumor after gross total resection: a case report
Frontiersgeneral

Late recurrence and histological progression of a cervical intradural extramedullary solitary fibrous tumor after gross total resection: a case report

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPdjIwcG5GcVk0TDR2YjM5T3RGNG1pWF9XQTIzanJFUnQ1N3JsbFJUZjlUYjVQb1c2R2U4U3EzWXl6czVwTEF2NkNXUUlnVnNLOEl3QlpKODI5U0R6MnQyOWdjU2xlLUhWRm1ZVEFxMzBGSHFjU1oxdWoxM2pxT2pvc21DOGxUMVQ4R1QtRGln?oc=5" target="_blank">Late recurrence and histological progression of a cervical intradural extramedullary solitary fibrous tumor after gross total resection: a case report</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
UCLA Health launches novel clinical trial for recurrent prostate cancer
UCLA Healthscience

UCLA Health launches novel clinical trial for recurrent prostate cancer

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPVzRpUXY2NGVMMFlZZ29LNmJSb1B0M0tEbFVBSmlUemFjRkpNNlJDT2hQNERFOUF0SklJNE83dUotQzlCU0lueVNiaUVNeFJKV1pPZkZUUGhKR1BRZ3NFdFBmQU96TXZETVJobVpKSXhJS25VZXo5UEdjREJYdEt0VG1kNFRxMWlIQzVCSEEwRzhmZDBsUGxIMVB5WVRHWUNVYkE?oc=5" target="_blank">UCLA Health launches novel clinical trial for recurrent prostate cancer</a>  <font color="#6f6f6f">UCLA Health</font>

Read Full StoryMore like this
Recurrent evolution of ligand-binding domain multiplicity fine-tunes TGFβ signaling in vertebrates
Naturetech

Recurrent evolution of ligand-binding domain multiplicity fine-tunes TGFβ signaling in vertebrates

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1BUEVONERNRDhRajJOUnEyRW1nN28zNU9fc2dBRVotTFZseHRQWFhkTVJuSi0xS3JSbjJOQzF4eFQ1UndmZHkwaFRVRlYzZXkwR2xiV1piT2dkaGNiSVAw?oc=5" target="_blank">Recurrent evolution of ligand-binding domain multiplicity fine-tunes TGFβ signaling in vertebrates</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
CancerNetworkgeneral

Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPX1NZYk02RFpIazFMWmFEcjhPOTd5dGNCWGwzQkowTFdyZ1pGWGhTMllYVmhGRFd5aHdORldGSXk3Y2hTWXZkbW9HWWNiNlJSWldHd040ZUI5MzY2ZjJRZzhWMUVTT1FBMEZQY2g0NWlLRHNRUmNxaUU3ckM3a3JjaDRhRDhHdUtjdC1IYkNybmMtY0RPUFNwVkpGQmRRWFp0Tk83NQ?oc=5" target="_blank">Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC</a>  <font color="#6f6f6f">CancerNetwork</font>

Read Full StoryMore like this
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
NEJMgeneral

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE1BTU0yT3ZBWGpleHliZTZ4enU3aWZTak14aFIzZEh6WUE1c2xCR0hfaFpfTWZaNHEyRDJKUGx1UXh5V0VGVFpHaW42amJCUDVUeFp5QlE3RldnR0ZWTHdxcw?oc=5" target="_blank">Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer
Business Wiretech

Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer

<a href="https://news.google.com/rss/articles/CBMijwNBVV95cUxNeEdXZTJmNV9RVG1Vd1huN0cwQjVWZDRQaG9ldnhmazlIYl8ycmFQcktSMjJKOUhRNE5Qd1BqeWVuUlI2cTc2OWVka3pMZzJjU0U0dlF4bzRUWmpEVGdnSy1rQk1Ha2c3dllWZ2hteld1TFNyQ21NbnpQRHRlSHhmc1VxeWFCd3AyemdmZThaVWw2TVFTc194Z2VuZnU5UWpnTmdfRk1wZXlJQkJNRUY5MGJpZnVlTDdJa194WW80UkRCZ29oQ19abTlOYzNKVlQyV2pPMm5JR1hYZTNndUtrRWEzNjdEdC16Q2xrY0JtbFl0eXRHUVZtaFUtN00xVkRoaE9mdWk5SUxfQVE0azN4RHpKTDhtRm9ZTGpqeXlqWjlYNEV6UGJXVUdHanpFMTFBNlppakNwNEJSblJUdFUtNnFSMnRQbWNGeWluaFhEc2lvc1dOZDRnQmkxX3k0TUNDYnBBOFBzSXpZYkg4SmxtcmhmVUJfUGZ6eF9LRHZ3RzJxaF8zanhUOXBYU0pzcDQ?oc=5" target="_blank">Merck Announces TroFuse-005 Trial Evaluating Sacituzumab Tirumotecan (Sac-TMT) Met Primary Endpoints of Overall Survival (OS) and Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Recurrent Ewing’s Sarcoma of the Chest Wall in an Adolescent Male Patient: A Complex Multimodal Management and Progressive Disease Course
Cureusgeneral

Recurrent Ewing’s Sarcoma of the Chest Wall in an Adolescent Male Patient: A Complex Multimodal Management and Progressive Disease Course

<a href="https://news.google.com/rss/articles/CBMihAJBVV95cUxQSmVUUnZFS0FQWkdmdnZxUEFJaW5rNk56a0p0UUpnTnhObV9ZRFVXbzdjY3JrcFZjUlh6WkNVTzJxTGppeE9MbGFJWE85U2tCN0V0TWhkdHdCTFBhUDNyR3NrRXBVYmxuSVFycGpZQWJMMzlHN1NBR244S1luUmZmOFN3c29nRlZhaHFrdDR3QzZyM1pEZjlVMHpwV0JfUHpjRUdia2ZsR1VjTHpLb3V6TF85MUo5Q1Y4QlROOVBSTmFRSGlEdHU1Q3E1QnJSLVMxY2ZFdFpsaTcwbS1DWDJFakdhekNYZlB2X2xaX0JKVWg1MmY3MTU4bmlmMmxZZmJsUkp1bA?oc=5" target="_blank">Recurrent Ewing’s Sarcoma of the Chest Wall in an Adolescent Male Patient: A Complex Multimodal Management and Progressive Disease Course</a>  <font color="#6f6f6f">Cureus</font>

Read Full StoryMore like this
UGN-102 linked with reduced risk of recurrence, progression, or death in LG-IR NMIBC
Urology Timesgeneral

UGN-102 linked with reduced risk of recurrence, progression, or death in LG-IR NMIBC

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxQTzRXTWlhWFEwTWZlVENxblF1d1M1YTlzSXI1ZjdoelRpZkF0OVVfZnRYOV85emhJZ2o2TEdwdm1uaFBCWkFLeXZiZFV3cjlIa1dhS3hxeDVGMUdhZUV4T3c1X0VaSXFqN0ZJcTNMRmJZSFBLR2txb1hTeVAyemJwbzdjOXhSdUJIVmhwXy1QUE9xNWdHeU8wZkg0SEsxV08yMmdKTVJjbG5UQ0kyRHFHTFpKYTQ1bG8?oc=5" target="_blank">UGN-102 linked with reduced risk of recurrence, progression, or death in LG-IR NMIBC</a>  <font color="#6f6f6f">Urology Times</font>

Read Full StoryMore like this
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
NEJMgeneral

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9VUVUwODNMdFdaZ1BRbENyUVVwNW9qdXhwdWFVUUV4bU13N3ZvNVpXLUFNcmZjejZuZ0hJOTk4VGQ4enVld0lUQkZ0R1pmTnFQSHpENkl2eHEtNHRlODdSaA?oc=5" target="_blank">Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer</a>  <font color="#6f6f6f">NEJM</font>

Read Full StoryMore like this
ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling
Naturetech

ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE80cWtzU1FsYi05ZEFpZ3NpTnpPMlU5aVlqUEhMOUtENC13RGVSSmJ5Q2JxTld5cDBFRGJNbFNPRDRuSVA5RGF1cGhaWmlhNG9PVV9WVC1GMUtpNW1vUzR3?oc=5" target="_blank">ABCC4 suppresses glioblastoma progression and recurrence by restraining cGMP-PKG signalling</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Nomogram for predicting post-progression-free survival in patients with recurrent pancreatic ductal adenocarcinoma after radical surgery: a retrospective analysis
Frontiersgeneral

Nomogram for predicting post-progression-free survival in patients with recurrent pancreatic ductal adenocarcinoma after radical surgery: a retrospective analysis

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQbjdPV2hfSG1QOVVxX2l2UExqeTFEVGxTZU11YXFEa3ZaS0FnbnFNRE53bGRzSDFXMWJ1UDhLekhfSnFqQmhQc1V3bmRIZUVNYjM4S0pVbzBVRV9ldWZ3Y3pwcy1zTV9kc0VIakVqeDAzTkJVWjdSTVJ0WTNxdDNiZmhsaWZBMlB6RVhrcFhB?oc=5" target="_blank">Nomogram for predicting post-progression-free survival in patients with recurrent pancreatic ductal adenocarcinoma after radical surgery: a retrospective analysis</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: Advancing precision oncology
Naturegeneral

Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: Advancing precision oncology

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBfWXdvRXlSSDhpQU1oMDBlTklKQi1tUE9nYkgwdW9tR29OWGxRMkU4YlVoN1hxSnJjaFd1MHBzMzA1N3UydXF6Q2l1TklyR1hiWEx2R2tJcktQdUtZUTRB?oc=5" target="_blank">Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: Advancing precision oncology</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Using Clinical Characteristics to Guide Treatment of Recurrent RCC After Adjuvant Pembrolizumab
ASCO Daily Newsgeneral

Using Clinical Characteristics to Guide Treatment of Recurrent RCC After Adjuvant Pembrolizumab

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOTnVZNmFvQ2c1RW4wam9nVHZaVENGQmpaWFc5Z0ptX0c2MUhmd2lvU3hnUHBURlA4Ylh2NDhkMl9TLVNtMm1BR0NLLUpNay1Fckh4b3U2VldldGxrbnFtRFhTRkYxdnlYOWJQeFpzdWNVMFRFMUVWTGI3Nkx2Q0g0LU82Ql9ucWlVZWl2S0dJTThyLWx5UHdEdmhGZkNZbTVFT2NPRU5KbXo4UWRIU1E?oc=5" target="_blank">Using Clinical Characteristics to Guide Treatment of Recurrent RCC After Adjuvant Pembrolizumab</a>  <font color="#6f6f6f">ASCO Daily News</font>

Read Full StoryMore like this
Prediction of chronic kidney disease progression using recurrent neural network and electronic health records
Naturescience

Prediction of chronic kidney disease progression using recurrent neural network and electronic health records

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE55NXJFQVpHZkhPMVc2a1h3dWg5TVhSWDRjX2Q0SmZaZzNNTFBPU0RndnFhMk1YVUFUNVQtVWxuUjZQdWdZZjRYa0RjSWZ0V3A3THVfcEpGam9HRm1yRnZV?oc=5" target="_blank">Prediction of chronic kidney disease progression using recurrent neural network and electronic health records</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer
Natureworld

Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9OeUM3ZGZXcUZhblZDZXFqdkpVak9wb0ZHN2NfQmpKWUljQ3padDZTZUdMLV9fdFJqTFhuUThtVkJMdFE0MHVyamhCeldONVRqN2xLQ0JpNmt0TTItSFBR?oc=5" target="_blank">Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Plant-Based Diets Reduce Prostate Cancer Progression and Recurrence
Physicians Committee for Responsible Medicinegeneral

Plant-Based Diets Reduce Prostate Cancer Progression and Recurrence

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNY1Nva0ZsaHE3X2c5T2RDWExUU3FEOHlxenoyZDlXczBSdjlSeVgzMTQwZ2xoZmxKSHdhaVNFWVBDdGlBR2tOakdaQ19DNTRtd0FMcW52OFN4QlkxVE1pcHFBQTFYTmd3c2NFWWNFSGsyRGdUTXN1dktIUFZZZzZ4cTk0UWNHa0haWE9YdWtmTjFNM0p4d1JzZVBFVktKSkFrVldBLXg5aC15cjAyOTZV?oc=5" target="_blank">Plant-Based Diets Reduce Prostate Cancer Progression and Recurrence</a>  <font color="#6f6f6f">Physicians Committee for Responsible Medicine</font>

Read Full StoryMore like this
Predictive Modeling of the Progression of Alzheimer’s Disease with Recurrent Neural Networks
Naturegeneral

Predictive Modeling of the Progression of Alzheimer’s Disease with Recurrent Neural Networks

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1XVUNZYTlsV0F0M3pFYlBKZmpCZGplUU9sTk9jUGg3Sm5MNkJaampMalN4UTZpcEliUzlhZWozZzJrSm5sM2hNUThyWWMxMDM5TVdEQ2lYaDA3VS1kVHNr?oc=5" target="_blank">Predictive Modeling of the Progression of Alzheimer’s Disease with Recurrent Neural Networks</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer
Naturegeneral

Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9uYUNHRFJ3SVhZR1h6UWo5Ti1ycXhKXzlBZk1kMDktZTNNSHh4OHZsSWs5WElkbTRWZ053QlctNThKQU1EQjg0NmJmR3FtcWZ1b05WWU9yYUFTX0ZkVW4w?oc=5" target="_blank">Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Temporal evolution and inter-patient heterogeneity in primary and recurrent head and neck squamous cell carcinoma
Naturegeneral

Temporal evolution and inter-patient heterogeneity in primary and recurrent head and neck squamous cell carcinoma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1SVFotM21OU195X0t2S1BXaGViQ2hvYmNic2VlRjN5cDAzdjJ3REhPNWdudk1RYnI2ZVdYYlRkX2JfVnZrZW4xX0k2YjVsOTd3aDVRVWVPc1p6UmlFRE80?oc=5" target="_blank">Temporal evolution and inter-patient heterogeneity in primary and recurrent head and neck squamous cell carcinoma</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Fuzuloparib Maintenance Therapy Improves Progression-Free Survival in Patients With Recurrent Ovarian Cancer
The ASCO Posttech

Fuzuloparib Maintenance Therapy Improves Progression-Free Survival in Patients With Recurrent Ovarian Cancer

<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxNU3NBVW5vNDlFQnZSX1pvTGplbmV1LTltX2VmeTMtYkxJeWZzOVZPS1B4elZwbklKNTF4aDljQ09ZM3FCdXlQQ3VhQ3FOYUZMWkRoV25RRWp2elNmLUtROGJVVGx6M0dWaVRxbkRLcjhlRXFrZVk1M2JGTVkyMkNGcXp3WWUtUW4xY01VQVp0aEtUVGpZZ1JqZjR1dXQ2dlhqbzR2Q29RMUJlNXM4UVJPcE1CUU9TcUFDTDdSTmJsdVY3S0RrYVh2SFdSZUJOMlNobG1IYmhoeHlTdGhzclVnTnE5bw?oc=5" target="_blank">Fuzuloparib Maintenance Therapy Improves Progression-Free Survival in Patients With Recurrent Ovarian Cancer</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Enzalutamide Plus Salvage Radiation Therapy Delays PSA Progression in PSA-Recurrent High-Risk Prostate Cancer
OncLivegeneral

Enzalutamide Plus Salvage Radiation Therapy Delays PSA Progression in PSA-Recurrent High-Risk Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxPdjhiSHV1ekNqbmdhLUFyTkVLbG42SnowQ2c3eGRXZXNoVUN0UEpJMlZ1cVNCNWg5QVhaRmRiQ2pWRUVsYzZYaURtYkJsRDllWE1vaDN2NVJKV3U5WGNiZU5xS0hMNmVTTDI3Q3UzWWp6cVJWX2NQX29DelV4X2ktVEQxeDRiamgxUl9FSlZEOG8wWW10eldFQ211S1BPOVZXSkp3R0RvU3BvcTZMZWw1ejlxM3o1Vm82YW1MWEVLZ1VMUU90ZEVyeloyb2FBcHkzQVluUQ?oc=5" target="_blank">Enzalutamide Plus Salvage Radiation Therapy Delays PSA Progression in PSA-Recurrent High-Risk Prostate Cancer</a>  <font color="#6f6f6f">OncLive</font>

Read Full StoryMore like this
Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer
Naturegeneral

Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5razFtV21QNmVaMUUxVFo0ZGtFWHVsb1RObkRJYzBsM00wNEpQaGViTFRzd0JmZkpmRzFyQ2o1TTJCOFhTZlpfVmdTOVNvcms5OU9VaUptMmhWQTMxY3Bv?oc=5" target="_blank">Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
"Progression of recurrent" — Live Google News Trends & Headlines